The Secretary of the Cognitive Sciences and Technologies Development Headquarters pointed out that the annual economic burden of Alzheimer's disease in the country is estimated at 20 trillion tomans. He stated that if targeted research and actions such as timely diagnosis and early intervention can reduce the economic burden of this disease by 10 percent, approximately 2 trillion tomans would be saved annually in direct and indirect costs.
The Economic Burden of Alzheimer's in the Country is 20 Trillion Tomans / 2 Trillion Tomans Savings with Targeted Research
The economic burden of Alzheimer's disease in Iran is estimated at 20 trillion tomans annually. Targeted research and early intervention could potentially save the country about 2 trillion tomans each year. This highlights the importance of investing in healthcare research to alleviate economic pressures.
👥 Key Players
📰 What Happened
The Secretary of the Cognitive Sciences and Technologies Development Headquarters announced that the annual economic burden of Alzheimer's disease in Iran is 20 trillion tomans. They emphasized that targeted research and early intervention could save the country 2 trillion tomans each year.
- The economic burden of Alzheimer's in Iran is estimated at 20 trillion tomans annually.
- A 10% reduction in this burden through research could save approximately 2 trillion tomans.
💡 Why It Matters
📚 Background
Alzheimer's disease is a growing concern globally, and its economic impact is particularly pronounced in countries with aging populations like Iran. Effective management and research are essential for mitigating these costs.
Translated from the original and edited for English readers. View original source →
Translation confidence: 85%